Federal Register #2026-17284

DEA Notice: Galephar Pharmaceutical Research Inc. Seeks Import Registration for Controlled Substances

This notice concerns Galephar Pharmaceutical Research Inc.'s application to the Drug Enforcement Administration (DEA) for importer registration of controlled substances. - Government Buyer: - U.S. Department of Justice, Drug Enforcement Administration (DEA) - OEM/Vendor: - Galephar Pharmaceutical Research Inc. - Products Requested: - Hydromorphone (drug code 9150) - For analytical purposes only - Morphine (drug code 9300) - For analytical purposes only - Unique/Notable Requirements: - Registration is strictly for importation of basic classes of controlled substances for analytical use - No authorization for importation of finished dosage forms for commercial sale - Comments or objections are invited from registered bulk manufacturers and applicants - Only Galephar Pharmaceutical Research Inc. is named as an applicant; no other vendors or OEMs are mentioned.

Description

Galephar Pharmaceutical Research Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). The application is a notice of application for registration as an importer of controlled substances. The company plans to import Hydromorphone and Morphine for analytical purposes only. Interested parties may submit comments or request a hearing on the application by September 24, 2026.

View original listing